Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface

Circulation Research

Volumn 94, Issue 11, 2004, Pages 1500-1506

  Davis, Faith B ^a,c   Mousa, Shaker A ^b   O'Connor, Laura ^b   Mohamed, Seema ^b   Lin, Hung Yun ^a,c   Cao, H James ^c   Davis, Paul J ^a,c,d,e  

^a STRATTON VA MEDICAL CENTER   (United States)

^b ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^c ORDWAY RESEARCH INSTITUTE   (United States)

^d WADSWORTH CENTER   (United States)

^e ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Angiogenesis; Basic fibroblast growth factor; Endothelial cell; Mitogen activated protein kinase; Thyroxine

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; COMPLEMENTARY DNA; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; LIOTHYRONINE; MIDOSTAURIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN KINASE C INHIBITOR; RNA; THYROID HORMONE; THYROXINE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLOOD VESSEL; CHICKEN; CHORIOALLANTOIS; ENDOTHELIUM CELL; ENZYME ACTIVATION; FIBROBLAST; HEART VENTRICLE HYPERTROPHY; HORMONE ACTION; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; CELL MEMBRANE; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLAST GROWTH FACTOR 2; HUMANS; MAP KINASE SIGNALING SYSTEM; NEOVASCULARIZATION, PHYSIOLOGIC; THYROXINE;

EID: 2942653137     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000130784.90237.4a     Document Type: Article

References (21)

1. Carmeliet P, Collen D. Molecular basis of angiogenesis. Role of VEGF and VE-cadherin. Ann N Y Acad Sci. 2000;902:249-262.
2. Tomanek RJ, Schatteman GC. Angiogenesis: new insights and therapeutic potential. Anat Rec. 2000;261:126-135.
3. Hudlicka O. Factors involved in capillary growth in the heart. Mol Cell Biochem. 1995;147:57-68.
4. Pages G, Milanini J, Richard DE, Berra E, Gothie E, Vinals F, Pouyssegur J. Signaling angiogenesis via p42/p44 MAP kinase cascade. Ann N Y Acad Sci. 2000;902:187-200.
5. Chilian WM, Wangler RD, Peters KG, Tomanek RJ, Marcus ML. Thyroxine-induced left ventricular hypertrophy in the rat. Anatomical and physiological evidence for angiogenesis. Circ Res. 1985;57:591-598.
6. Tomanek RJ, Busch TL. Coordinated capillary and myocardial growth in response to thyroxine treatment. Anat Rec. 1998;251:44-49.
7. Pennock GD. Cardiac effects of 3,5-diiodothyropropionic acid, a thyroid hormone analog with inotropic selectivity. J Pharmacol Exp Ther. 1992; 263:163-169.
8. Tomanek RJ, Zimmerman MB, Suvarna PR, Morkin E, Pennock GD, Goldman S. A thyroid hormone analog stimulates angiogenesis in the post-infarcted rat heart. J Mol Cell Cardiol. 1998;30:923-932.
9. Auerbach R, Kubai L, Knighton D, Folkman J. A simple procedure for the long-term cultivation of chicken embryos. Dev Biol. 1974;41: 391-394.
10. Dupont E, Falardeau P, Mousa SA, Dimitriadou V, Pepin MC, Wang T, Alaoui-Jamali MA. Antiangiogenic and antimetastatic properties of Neovastat (AE-941), an orally active extract derived from cartilage tissue. Clin Exp Metastasis. 2002;19:145-153.
11. Kim S, Bell K, Mousa SA, Varner JA. Regulation of angiogenesis in vivo by ligation of integrin α5/β1 with the central cell-binding domain of fibronectin. Am J Path. 2000;156:1345-1362.
12. Colman RW, Pixley RA, Sainz IM, Song JS, Isordia-Salas I, Mohamed SN, Powell JA Jr, Mousa SA. Inhibition of angiogenesis by antibody blocking the action of proangiogenic high-molecular-weight kininogen. J Thromb Haemost. 2003;1:164-170.
13. Lin H-Y, Davis FB, Gordinier JK, Martino LJ, Davis PJ. Thyroid hormone induces activation of mitogen-activated protein kinase in cultured cells. Am J Physiol. 1999;276:C1014-C1024.
14. Davis PJ, Shih A, Lin H-Y, Davis FB. Thyroxine promotes association of mitogen-activated protein kinase (MAPK) and nuclear thyroid hormone receptor (TR) and causes serine phosphorylation of TR. J Biol Chem. 2000;275:38032-38039.
15. Shih A, Lin H-Y, Davis FB, Davis PJ. Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase. Biochemistry. 2001;40:2870-2878.
16. Lin H-Y, Shih A, Davis FB, Davis PJ. Thyroid hormone promotes phosphorylation of STAT3 and potentiates the action of EGF in cultured cells. Biochem J. 1999;338:427-432.
17. Collin-Osdoby P, Rothe L, Bekker S, Anderson F, Huang Y, Osdoby P. Basic fibroblast growth factor stimulates osteoclast recruitment, development, and bone pit resorption in association with angiogenesis in vivo on the chick chorioallantoic membrane and activates isolated avian osteoclast resorption in vitro. J Bone Miner Res. 2002;17:1859-1871.
18. Tanaka K, Abe M, Sato Y. Roles of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in the signal transduction of basic fibroblast growth factor in endothelial cells during angiogenesis. Jpn J Cancer Res. 1999;90:647-654.
19. Tomanek RJ, Doty MK, Sandra A. Early coronary angiogenesis in response to thyroxine: growth characteristics and upregulation of basic fibroblast growth factor. Circ Res. 1998;82:587-593.
20. Turner HE, Harris AL, Melmed S, Wass JAH. Angiogenesis in endocrine tumors. Endocr Rev. 2003;24:600-632.
21. Pircher TJ, Flores-Morales A, Mui AL, Saltiel AR, Norstedt G, Gustafsson JA, Haldosen LA. Mitogen-activated protein kinase kinase inhibition decreases growth hormone stimulated transcription mediated by STAT5. Mol Cell Endocrinol. 1997;133:169-176.